Table 1.
Summary statistics of all variables of bladder, prostate and kidney cancer
| 2012 | 2018 | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer type | HDI | ASI | MIR | Survival | HDI | ASI | MIR | Survival |
| prostate | 0.669/0.702 (0.519–0.805) | 41.0/35.4 (16.2–58.3) | 0.542/0.543 (0.338–0.777) |
82.2/87.3 (76.6–91.1) |
0.705/0.735 (0.582–0.826) | 38.7/35.2 (15.8–55.8) | 0.432/0.434 (0.276–0.606) |
84.1/88.2 (80.6–91.4) |
| bladder |
5.32/3.2 (1.90–7.95) |
0.473/0.444 (0.347–0.631) |
NA |
5.31/3.00 (1.90–8.13) |
0.497/0.497 (0.344–0.643) |
NA | ||
| kidney |
4.05/2.60 (1.20–6.05) |
0.582/0.604 (0.386–0.780) |
NA |
4.04/2.30 (1.19–6.43) |
0.518/0.492 (0.360–0.684) |
NA | ||
The statistics are presented as mean/median (inter quartile range). HDI, Human Development Index. ASI: Age-Standardized Incidence. MIR, Mortality-to-Incidence Ratio